Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Droxine
|
| gptkbp:brand |
gptkb:Euthyrox
gptkb:Synthroid Unithroid Tirosint |
| gptkbp:category |
gptkb:A
compatible |
| gptkbp:clinical_trial |
thyroid hormone replacement therapy
suppression of TSH secretion |
| gptkbp:contraindication |
adrenal insufficiency
thyrotoxicosis untreated subclinical hyperthyroidism |
| gptkbp:dosage_form |
oral tablet
|
| gptkbp:effective_date |
gptkb:1999
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:has_ability |
100 mcg
112 mcg 137 mcg 150 mcg 175 mcg 200 mcg 25 mcg 50 mcg 125 mcg 75 mcg |
| https://www.w3.org/2000/01/rdf-schema#label |
Levoxyl
|
| gptkbp:ingredients |
gptkb:levothyroxine
|
| gptkbp:interacts_with |
gptkb:warfarin
antacids iron supplements calcium supplements certain antidepressants |
| gptkbp:is_used_for |
hypothyroidism
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
King Pharmaceuticals
|
| gptkbp:previous_name |
levothyroxine sodium
|
| gptkbp:side_effect |
headache
weight loss diarrhea insomnia nervousness sweating hair loss increased appetite |
| gptkbp:storage |
room temperature
protected from light protected from moisture |